Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

XMD-17-51 (Synonyms: XMD17-51)

Catalog No. T22460 Copy Product Info
Purity: 99.04%
🥰Excellent
XMD-17-51 has DCLK1 kinase inhibitory activity, inhibits DCLK1 and cell proliferation, and can be used in lung cancer research.

XMD-17-51

Copy Product Info
🥰Excellent
Catalog No. T22460
Synonyms XMD17-51

XMD-17-51 has DCLK1 kinase inhibitory activity, inhibits DCLK1 and cell proliferation, and can be used in lung cancer research.

XMD-17-51
Cas No. 1628614-50-5
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$293-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.04%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
XMD-17-51 has DCLK1 kinase inhibitory activity, inhibits DCLK1 and cell proliferation, and can be used in lung cancer research.
In vitro
Overexpression of DCLK1 was found to reduce the antiproliferative effect of XMD-17-51 in the A549 cell line, increasing its IC50 from 27.575 µM to 53.197 µM and vice versa. In a cell-free assay, XMD-17-51 showed an inhibitory effect on DCLK1 kinase activity with an IC50 of 14.64 nM. In non-small cell lung cancer (NSCLC) cell lines, XMD-17-51 also reduced DCLK1 protein expression, which resulted in inhibition of cell proliferation, epithelial-mesenchymal transition (EMT), and stem cell characterization. [1]
SynonymsXMD17-51
Chemical Properties
Molecular Weight404.47
FormulaC21H24N8O
Cas No.1628614-50-5
SmilesO=C1C=2C=CC=CC2N(C3=NC(=NC=C3N1C)NC=4C=NN(C4)C5CCNCC5)C
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
Ethanol: 40 mg/mL (98.89 mM), Sonication is recommended.
DMSO: 40 mg/mL (98.89 mM), Sonication is recommended.
H2O: 1 mg/mL (2.47 mM), Sonication is recommended.
Solution Preparation Table
H2O/Ethanol/DMSO
1mg5mg10mg50mg
1 mM2.4724 mL12.3619 mL24.7237 mL123.6186 mL
Ethanol/DMSO
1mg5mg10mg50mg
5 mM0.4945 mL2.4724 mL4.9447 mL24.7237 mL
10 mM0.2472 mL1.2362 mL2.4724 mL12.3619 mL
20 mM0.1236 mL0.6181 mL1.2362 mL6.1809 mL
50 mM0.0494 mL0.2472 mL0.4945 mL2.4724 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy XMD-17-51 | purchase XMD-17-51 | XMD-17-51 cost | order XMD-17-51 | XMD-17-51 chemical structure | XMD-17-51 in vitro | XMD-17-51 formula | XMD-17-51 molecular weight